DPT expands plant in San Antonio

San Antonio-based CDMO DPT Laboratories and its sister company in Canada have completed their $10 million in facility upgrades. About 80% of that was spent on DPT's operation in San Antonio, where it has a 450,000-square-foot manufacturing plant, as well as a formulation facility.

The company says that work in Texas included significant upgrades to production filling lines, a new compounding suite as well as security improvements to improve GMP compliance and restrict access to the manufacturing floor. The company makes both prescription and over-the-counter products in Texas. The plant there includes a 60,000-square-foot cGMP aerosol manufacturing facility.

The upgrades at Confab, its manufacturing site for complex solid dose, semisolid and liquid products, included work for R&D upgrades, DPT said in a statement.

The CDMO also has manufacturing site in Lakewood, NJ. In 2012, that site received an FDA warning letter for a number problems including release testing failures for an ointment that raised red flags at the FDA. The company responded quickly and received a closeout letter from the regulator 6 months later.

- here's the announcement

Suggested Articles

Gilead expects to sell 1 million to 1.5 million treatment courses of remdesivir in 2020. That means about $3.5 billion in sales, one analsyt figures.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Warp Speed's largest outlay to date, the funding will cover development and manufacturing scale-up of a vaccine that uses proven Sanofi technology.